Role of CYP2E1 in the Epoxidation of Acrylamide to Glycidamide and Formation of DNA and Hemoglobin Adducts

Berger, A. R., and Schaumburg, H. H. (1995). Human peripheral nerve disease (peripheral neuropathies). In The Axon: Structure, Function and Pathophysiology. (S. G. Waxman, J. D. Kocsis, and P. K. Stys, Eds.), pp. 648–660. Oxford University Press, New York.

Bergmark, E. (1997). Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem. Res. Toxicol.10,78–84.

Bergmark, E., Calleman, C. J., and Costa, L. G. (1991). Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol.111,352–363.

Bergmark, E., Calleman, C. J., He, F., and Costa, L. G. (1993). Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol.120,45–54.

Bucher, J. R., Huff, J., Haseman, J. K., Eustis, S. L., Peters, A., and Toft, J. D. (1990). Neurotoxicity and carcinogenicity of N-methylolacrylamide in F344 rats and B6C3F1 mice. J. Toxicol. Environ. Health31,161–77.

Bull, R. J., Robinson, M., Laurie, R. D., Stoner, G. D., Greisiger, E., Meier, J. R., and Stober, J. (1984a). Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res.44,107–111.

Bull, R. J., Robinson, M., and Stober, J. A. (1984b). Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett.24,209–212.

Calleman, C. J., Bergmark, E., and Costa, L. G. (1990). Acrylamide is metabolized to glycidamide in the rat: Evidence from hemoglobin adduct formation. Chem. Res. Toxicol.3,406–412.

Damjanov, I., and Friedman, M. A. (1998). Mesotheliomas of tunica vaginalis testis of Fischer 344 (F344) rats treated with acrylamide: A light and electron microscopy study. In Vivo12,495–502.

Dearfield, K. L., Douglas, G. R., Ehling, U. H., Moore, M. M., Sega, G. A., and Brusick, D. J. (1995). Acrylamide: A review of its genotoxicity and an assessment of heritable genetic risk. Mut. Res.330,71–99.

Doerge, D. R., Gamboa da Costa, G., McDaniel, L. P., Churchwell, M. I. Twaddle, N. C., and Beland, F. A. (2005a). DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mut. Res.580,131–142.

Doerge, D. R., Young, J. F., McDaniel, L. P., Twaddle, N. C., and Churchwell, M. I. (2005b). Toxicokinetics of acrylamide in B6C3F1 mice. Toxicol. Appl. Pharmacol.202,258–267.

Fennell, T. R., Snyder, R. W., Krol, W. L., and Sumner, S. C. (2003). Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. Toxicol. Sci.71,164–175.

Fennell, T. R., Sumner, S. C., Snyder, R. W., Burgess, J., Spicer, R., Bridson, W. E., and Friedman, M. A. (2005). Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol. Sci.85,447–459.

Friedman, M. A., Dulak, L. H., and Stedham, M. A. (1995). A lifetime oncogenicity study in rats treated with acrylamide. Fund. Appl. Toxicol.27,95–105.

Friedman, M. (2003). Chemistry, biochemistry, and safety of acrylamide. A review. J. Agric. Food Chem.51,4504–4526.

Gamboa da Costa, G., Churchwell, M. I., Hamilton, L. P., Beland, F. A., Marques, M. M., and Doerge, D. R. (2003). DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem. Res. Toxicol.16,1328–1337.

Ghanayem, B. I., Witt, K. L., El-Hadri, L., Hoffler, U., Kissling, G. E., Shelby, M. D., and Bishop, J. B. (2005a). Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: Evidence supporting a glycidamide-mediated mechanism. Biol. Reprod72,157–163.

Ghanayem, B. I., Witt, K. L., Kissling, G. E., Tice, R. R., and Recio, L. (2005b). Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: Evidence consistent with a glycidamide-mediated effect. Mutat. Res. (In press).

Ghanayem, B. I., Wang, H., and Sumner, S. (2000). Using cytochrome P-450 gene knock-out mice to study chemical metabolism, toxicity, and carcinogenicity. Toxicol. Pathol.28,839–850.

Hemminki, K. (1993). DNA adducts, mutations and cancer. Carcinogenesis14,2007–2012.

Hoffler, U., El-Masri, H., and Ghanayem, B. I. (2003). Cytochrome P4502E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: Comparative studies using CY2E1-null and wild-type mice. J. Pharmacol. Exp. Therap.305,557–564.

Holland, N., Ahlborn, T., Turteltaub, K., Mrkee, C., Moore, D., 2nd, Wyrobek, A. J., and Smith, M. T. (1999). Acrylmaide cause preimplantation abnormalities in embryos and induces chromatin adducts in male germ cells of mice. Reprod. Toxicol.13,167–178.

IARC (1994). Acrylamide. IARC Monogr. Eval. Carcinog. Risks Hum.60,389–433.

Johnson, K. A., Gorzinski, S. J., Bonder, K. M., Campbell, R. A., Wolf, C. H., Friedman, M. A., and Mast, R. W. (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol.85,154–168.

Koskinen, M., and Plna, K. (2000). Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo. Chem. Biol. Interact.129,109–229.

Lee, S., Buters, J., Pineau, T., Fernadex-Salguero, P., and Gonzalez, F. (1996). Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem.271,12063–12067.

LeQuesne, P. M. (1991). Acrylamide. Exp. Clin. Neurotoxicol.25,309–325.

Melnick, R. L. (2002). Carcinogenicity and mechanistic insights on the behavior of epoxides and epoxide-forming chemicals. Ann. N.Y. Acad. Sci.982,177–189.

Mowrer, J., Tornqvist, M., Jensen, S., and Ehrenberg, L. (1986). Modified Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents. Toxicol. Env. Chem.11,215–231.

Rosen, J., and Hellenas, K. E. (2002). Analysis of acrylamide in cooked foods by liquid chromatography tandem mass spectrometry. Analyst127,880–882.

Schettgen, T., Broding, H. C., Angerer, J., and Drexler, H. (2002). Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol. Lett.134,65–70.

Segerback, D., Calleman, C. J., Schroeder, J. L., Costa, L. G., and Faustman, E. M. (1995). Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis16,1161–1165.

Sega, G. (1991). Adducts in sperm protamine and DNA vs. mutation frequency. Prog. Clin. Biol. Res.372,521–530.

Sega, G., Alcota, R., Tancongco, C., and Brimer, P. (1989). Acrylamide binding to the DNA and protamine of spermiogenic stages in the mouse and its relationship to genetic damage. Mutat. Res.216,221–230.

Shelby, M., Cain, K., Hughes, L., Braden, L., and Generoso, W. (1986). Dominant lethal effects of acrylamide in male mice. Mutat. Res.173,35–40.

Smith, C. J., Perfetti, T. A., Rumple, M. A., Rodgman, A., and Doolite, D. J. (2001). “IARC group 2B carcinogens” reported in cigarette mainstream smoke. Food Chem. Toxicol.39,183–205.

Sumner, S. C., Fennell, T. R., Moore, T. A., Chanas, B., Gonzalez, F., and Ghanayem, B. I. (1999). Role of cytochrome P4502E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol.12,1110–1116.

Sumner, S. C., Williams, C. C., Snyder, R. W., Krol, W. L., Asgharian, B., and Fennell, T. R. (2003). Acrylamide: A comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol. Sci.75,260–270.

Tareke, E., Rydberg, P., Karlsson, P., Eriksson, S., and Tornqvist, M. (2002). Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem.50,4998–5006.

Tyl, R. W., and Friedman, M. A. (2003). Effects of acrylamide on rodent reproductive performance. Reprod. Toxicol.17,1–13.

Tyl, R. W., Marr, M. C., Myers, C. B., Ross, W. P., and Friedman, M. A. (2000). Relationship between acrylamide reproductive and neurotoxicity in male rats. Reprod. Toxicol.14,147–157.

Twaddle, N. C., Churchwell, M. C., McDaniel, L. P., and Doerge, D. R. (2004a). Autoclave sterilization produces acrylamide in rodent diets: Implications for toxicity testing. J. Agric. Food Chem.52,4344–4349.

Twaddle, N. C., Hamilton, L. P., Gamboa da Costa, G., Churchwell, M. I., Beland, F. A., and Doerge, D. R. (2004b). Determination of acrylamide and glycidamide serum toxicokinetics in B6C3F1 mice using LC-ES/MS/MS. Cancer Lett.207,9–17.

U.S. Department of Health and Human Services (1986). National Institutes of Health Guide of the care and use of laboratory animals. NIH Publication no. 86–23, National Institutes of Health, Bethesda, MD.

Weiss, G. (2002). Cancer risks. Acrylamide in food: Uncharted territory. Science297,27.

Wu, Y. Q., Yu, A. R., Tang, X. Y., Zhang, J., and Cui, T. (1993). Determination of acrylamide metabolite, mercapturic acid by high pressure liquid chromatography. Biomed. Environ. Sci.6,273–280.